Skip to content. | Skip to navigation

Personal tools
Log in
You are here: Home › Know-who Know-how Directory › From A to Z › Fornix BioSciences N.V.

Fornix BioSciences N.V.

Business focus: Fornix BioSciences N.V. is focused on the development and sale of diagnostic/therapeutic allergen products, the distribution of medical aids and nursing disposables and the distribution of patented drugs in the EU.
Fornix2       

Fornix BioSciences N.V.
Vijzelweg 11
8243 PM  Lelystad
Website Fornix BioSciences N.V.
E-mail Fornix BioSciences N.V.
T +31 (0)320 26 79 00
F +31 (0)320 26 77 91

Employees in Amsterdam: 200
Year of foundation: 1999

Company Profile

Fornix BioSciences N.V. is a listed company (Euronext Amsterdam: AFORBI) with business locations in Lelystad and Beuningen. The concern, with 200 employees, has a large number of clients in the Netherlands and other European countries. The activities are organised into three divisions, the Allergy division, the division Medical Aids and the Trading division. The concern intends to achieve a prominent position in the niches in which the concern operates. Fornix BioSciences also intends to make a contribution to the improvement of the health and quality of life of people.

Keywords

  • Listed company
  • Immunotherapy
  • Allergy
  • Medical aids/nursing disposables
  • Health




Document Actions

Find your life sciences partner in the Amsterdam BioMed Cluster

Find your life sciences partner in the Amsterdam BioMed Cluster

Column

Penny-wise!

Synaps bij column Arjen Brussaard, foto CNCR.nl

By Arjen Brussaard

Recently the topsector plan Life Sciences & Health was published and presented to Minister Verhagen, of the so-called ELI Ministry. The document is an amazing compressed 60-pager, based on months of hard work by the group of experts chaired by Roel Fonville, and summarizes the conclusions after dozens of 1-to-1 meetings, five regional group sessions with dozens of opinion leaders and after having received over 170 (!) memo's, white papers and letters of intent.
More...